Science and Medicine Group (SMG) is the parent organization behind five specialized market research and intelligence brands — BioInformatics, IMV, Kalorama Information, SDi, and IBO. Since 1994, SMG has assembled a portfolio of industry-leading research brands that serve commercial teams, product strategists, investors, and executives across life science, diagnostics, analytical instruments, and medical imaging. Each brand was built or acquired because a specific segment of the market needed deeper, more specialized intelligence than broad market research could deliver. SMG provides the shared infrastructure, expert networks, and cross-sector resources that make each brand stronger — while each brand retains the deep domain focus and industry identity that clients have trusted for decades.  

 SMG's Insights division offers four core product types across its five brands. Syndicated Reports are annual flagship publications covering market sizing, five-year forecasts, vendor share, and competitive analysis — trusted by virtually every major company in their respective sectors. Custom Market Research delivers tailored engagements designed around your specific strategic questions, from product development to pricing strategy to go-to-market planning. Key Reports and Accelerated Insights provide focused, fast-turn intelligence on high-priority market questions for when decisions can't wait for a full research cycle. Finally, Expert Networks and Advisory connect clients with the largest and most qualified networks of scientific and clinical experts across SMG's five brands — an unmatched resource for primary research and strategic advisory. The right product depends on your specific question, timeline, and sector — our team will help you identify the best fit.  

 BioInformatics has been the leading research and advisory partner to the life science and diagnostics industries since 1994. What sets BioInformatics apart is direct access to the Science Advisory Board — a proprietary network of over 50,000 scientific experts — enabling primary research that goes well beyond secondary data analysis. BioInformatics bridges the gap between the world's leading life science suppliers and the scientists who are shaping the future of discovery, transforming raw data into strategic clarity needed to drive product innovation and market growth. This depth of expert access — combined with 30+ years of tracking researcher loyalty, switching behavior, and purchasing decisions — makes BioInformatics uniquely equipped to answer the questions that drive commercial success in the life science tools, reagents, and consumables markets.

 IMV serves three primary audiences: medical imaging equipment manufacturers, diagnostic imaging service organizations, and private equity firms with healthcare portfolio interests. Imaging OEMs rely on IMV's installed base databases — covering MRI, CT, PET, ultrasound, and nuclear medicine — to understand competitive equipment penetration, identify displacement opportunities, and plan product launch strategies by geography and facility type. Service organizations use IMV's ServiceTrak data to identify high-value service contract and maintenance opportunities at the facility level. Investors and PE firms use IMV's market sizing and five-year forecasts to support due diligence and inform capital allocation across the diagnostic imaging sector. IMV has delivered trusted market intelligence to the imaging industry since 1977, backed by decades of primary research and proprietary provider data.  

 Kalorama Information has been a trusted leader in life science market intelligence since 1986, specializing in in vitro diagnostics (IVD), medical devices, biotechnology, and pharmaceuticals. Kalorama's reports are designed for top IVD manufacturers, investors, and healthcare stakeholders who need precise market sizing, competitive analysis, and growth strategies rather than broad, generalist research. Coverage spans the full diagnostics landscape — from point-of-care and molecular diagnostics to NGS and genomics — as well as medical devices, pharmaceuticals, and emerging therapy areas including cell and gene therapy. Kalorama's goal is to turn data into clear, actionable insights so organizations can make smarter decisions, identify growth opportunities, and stay ahead of change. Reports are available as single-user licenses or enterprise subscriptions, with global coverage including country-level and regional breakdowns. 

 The SDi Global Assessment Report is the annual flagship market intelligence publication for the life science and analytical instrumentation industry, now in its 45th edition. It provides market sizing, five-year demand forecasts with CAGR through 2030, vendor market share, competitive analysis, and recent market developments across more than 80 instrument technologies — including chromatography, mass spectrometry, flow cytometry, PCR, spectroscopy, lab automation, and beyond. Every technology chapter delivers the same depth of analysis: market demand by product type, end market, and industry sector; regional analysis across eight major geographies; lab function segmentation; application growth mapping; and a supplier participation matrix. The report is trusted by virtually every major instrumentation company in the United States, Europe, and Japan because it has been the most comprehensive and accurate source of instrumentation market data for over four decades.  

 While SDi's Global Assessment Report delivers the deep annual benchmark — market sizing, vendor share, five-year forecasts, and competitive analysis across 80+ instrument technologies — IBO provides the continuous intelligence layer that keeps subscribers informed between report cycles. IBO covers the analytical and life science instrument industry with ongoing news, data, analysis, and strategic feature articles: company financial performance, M&A activity, new product launches, earnings results, and emerging market trends. Together, SDi and IBO give instrumentation companies the most complete market intelligence picture available — the rigorous annual benchmark plus real-time awareness of the competitive moves and market shifts that can't wait for the next report. IBO is the right resource for competitive intelligence teams, business development leaders, investor relations professionals, and any commercial team that needs to track how the instrument industry is moving week to week.